Cottone M, Virdone R, Fusco G, Orlando A, Turri M, Caltagirone M, Maringhini A, Sciarrino E, Demma I, Nicoli N
Clinica Medica R, Ospedale Cervello, Divisione di Medicina, Palermo, Italy.
Gastroenterology. 1989 Jun;96(6):1566-71. doi: 10.1016/0016-5085(89)90528-3.
The present study deals with the natural history of 37 asymptomatic patients with cirrhosis and hepatocellular carcinoma, 25 with 2-9-cm tumors who were not surgically treated (first group) and 12 with tumors smaller than 4 cm who underwent resection (second group). All patients were in Child's A class. Two-year survival (according to life-table analysis by the Kaplan-Meier method) was 50% in the first group and 39% in the second group. This difference was not significant. In the first group no relation was found between survival and initial tumor size or alpha-fetoprotein levels. Ultrasound examinations at 3-mo intervals revealed the following patterns of tumor growth: (a) no significant growth during the follow-up (9 patients); (b) significant growth (tumor size at least doubling) only in the final stage of the disease (11 patients); (c) initial significant growth followed by a period of no increase in size (5 patients). These findings show that in our geographical area (a) 2-yr survival of untreated asymptomatic patients with hepatocellular carcinoma associated with cirrhosis does not differ from that of similar patients undergoing resection and (b) the tumor can exhibit long periods of no growth alternating with periods of exponential growth.
本研究探讨了37例无症状肝硬化合并肝细胞癌患者的自然病史,其中25例肿瘤大小为2 - 9厘米且未接受手术治疗(第一组),12例肿瘤小于4厘米且接受了切除术(第二组)。所有患者均为Child's A级。根据Kaplan-Meier法进行生命表分析,第一组的两年生存率为50%,第二组为39%。这种差异不显著。在第一组中,未发现生存率与初始肿瘤大小或甲胎蛋白水平之间存在关联。每隔3个月进行的超声检查显示了以下肿瘤生长模式:(a)随访期间无显著生长(9例患者);(b)仅在疾病末期出现显著生长(肿瘤大小至少翻倍)(11例患者);(c)初始显著生长后有一段时间大小无增加(5例患者)。这些发现表明,在我们所在的地理区域,(a)未经治疗的无症状肝硬化合并肝细胞癌患者的两年生存率与接受切除术的类似患者无差异,(b)肿瘤可表现出长时间的无生长期与指数生长期交替出现。